Markets

UroGen Pharma Ltd. (URGN) Form 144 Filed on June 9

Published on 6/9/2026

#URGN#Form144#insidertransactions
UroGen Pharma Ltd. (URGN) Form 144 Filed on June 9

AI Summary

Summarized by AI from the source below

UroGen Pharma Ltd. (URGN) filed Form 144 on June 9 for potential transactions involving the sale of shares by insiders. This filing allows for the sale of shares under specific restrictions, which could influence the stock's liquidity. The current trading volume and any changes in share ownership following this filing are relevant for investor sentiment. Monitoring such regulatory filings helps investors gauge potential stock movements and insider activity.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Fuller Smith & Turner Share Transfer Announced for Director
Markets

Fuller Smith & Turner Share Transfer Announced for Director

Jul 24

S&P/TSX Composite Up Over 200 Points, U.S. Markets Higher
Markets

S&P/TSX Composite Up Over 200 Points, U.S. Markets Higher

Jul 24

Intel (INTC) and Oracle Stocks Show Major Premarket Moves
Markets

Intel (INTC) and Oracle Stocks Show Major Premarket Moves

Jul 24

TSX Futures Rise Amid Middle East Tensions, U.S. Tariffs Impact
Markets

TSX Futures Rise Amid Middle East Tensions, U.S. Tariffs Impact

Jul 24